Mohsin Imam

Mohsin Imam

Director Director DIN 09290654
DIN 09290654 First appointment Aug 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2021
Shareholding value Locked Premium profile

About Mohsin Imam

Data last updated:

Mohsin Imam has 5 years in corporate governance. Formerly with 1 company, such as Ukr Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09290654
Primary Designation Director
First Appointment 23 Aug 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Ukr Pharmaceuticals Private Limited U24297BR2021PTC053618
Director23 Aug 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ukr Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohsin Imam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohsin Imam

Mohsin Imam has 5 years in corporate governance. Formerly with 1 company, such as Ukr Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Mohsin Imam is associated with 0 companies as a director.

Mohsin Imam has expertise in General Business.

Mohsin Imam has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available